89 related articles for article (PubMed ID: 15150086)
21. miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia.
Jiang X; Hu C; Arnovitz S; Bugno J; Yu M; Zuo Z; Chen P; Huang H; Ulrich B; Gurbuxani S; Weng H; Strong J; Wang Y; Li Y; Salat J; Li S; Elkahloun AG; Yang Y; Neilly MB; Larson RA; Le Beau MM; Herold T; Bohlander SK; Liu PP; Zhang J; Li Z; He C; Jin J; Hong S; Chen J
Nat Commun; 2016 Apr; 7():11452. PubMed ID: 27116251
[TBL] [Abstract][Full Text] [Related]
22. The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.
Hillion J; Roy S; Heydarian M; Cope L; Xian L; Koo M; Luo LZ; Kellyn K; Ronnett BM; Huso T; Armstrong D; Reddy K; Huso DL; Resar LMS
Gynecol Oncol; 2016 Jun; 141(3):580-587. PubMed ID: 27001612
[TBL] [Abstract][Full Text] [Related]
23. The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.
Sumter TF; Xian L; Huso T; Koo M; Chang YT; Almasri TN; Chia L; Inglis C; Reid D; Resar LM
Curr Mol Med; 2016; 16(4):353-93. PubMed ID: 26980699
[TBL] [Abstract][Full Text] [Related]
24. STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)-STAT3 pathway.
Belton A; Xian L; Huso T; Koo M; Luo LZ; Turkson J; Page BD; Gunning PT; Liu G; Huso DL; Resar LM
Leuk Lymphoma; 2016 Nov; 57(11):2681-4. PubMed ID: 26952843
[No Abstract] [Full Text] [Related]
25. Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells.
Lopez-Bertoni H; Lal B; Michelson N; Guerrero-Cázares H; Quiñones-Hinojosa A; Li Y; Laterra J
Oncogene; 2016 Sep; 35(37):4903-13. PubMed ID: 26898758
[TBL] [Abstract][Full Text] [Related]
26. HMGA1-pseudogenes and cancer.
De Martino M; Forzati F; Arra C; Fusco A; Esposito F
Oncotarget; 2016 May; 7(19):28724-35. PubMed ID: 26895108
[TBL] [Abstract][Full Text] [Related]
27. Heat shock protein 90 is involved in the regulation of HMGA2-driven growth and epithelial-to-mesenchymal transition of colorectal cancer cells.
Kao CY; Yang PM; Wu MH; Huang CC; Lee YC; Lee KH
PeerJ; 2016; 4():e1683. PubMed ID: 26893968
[TBL] [Abstract][Full Text] [Related]
28. Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes.
Pierantoni GM; Conte A; Rinaldo C; Tornincasa M; Gerlini R; Federico A; Valente D; Medico E; Fusco A
Oncotarget; 2015 Jul; 6(19):17342-53. PubMed ID: 26009897
[TBL] [Abstract][Full Text] [Related]
29. High mobility group a proteins as tumor markers.
Pallante P; Sepe R; Puca F; Fusco A
Front Med (Lausanne); 2015; 2():15. PubMed ID: 25859543
[TBL] [Abstract][Full Text] [Related]
30. HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs.
Esposito F; De Martino M; Petti MG; Forzati F; Tornincasa M; Federico A; Arra C; Pierantoni GM; Fusco A
Oncotarget; 2014 Sep; 5(18):8341-54. PubMed ID: 25268743
[TBL] [Abstract][Full Text] [Related]
31. The high mobility group A1 molecular switch: turning on cancer - can we turn it off?
Huso TH; Resar LM
Expert Opin Ther Targets; 2014 May; 18(5):541-53. PubMed ID: 24684280
[TBL] [Abstract][Full Text] [Related]
32. Hitting the bull's eye: targeting HMGA1 in cancer stem cells.
Yanagisawa BL; Resar LM
Expert Rev Anticancer Ther; 2014 Jan; 14(1):23-30. PubMed ID: 24410339
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of high mobility group A1 protein in human uveal melanomas: implication for prognosis.
Qu Y; Wang Y; Ma J; Zhang Y; Meng N; Li H; Wang Y; Wei W
PLoS One; 2013; 8(7):e68724. PubMed ID: 23935884
[TBL] [Abstract][Full Text] [Related]
34. HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells.
Shah SN; Cope L; Poh W; Belton A; Roy S; Talbot CC; Sukumar S; Huso DL; Resar LM
PLoS One; 2013; 8(5):e63419. PubMed ID: 23658826
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice.
Di Cello F; Shin J; Harbom K; Brayton C
Biochem Biophys Res Commun; 2013 Apr; 434(1):70-4. PubMed ID: 23545254
[TBL] [Abstract][Full Text] [Related]
36. HMGA1 overexpression correlates with relapse in childhood B-lineage acute lymphoblastic leukemia.
Roy S; Di Cello F; Kowalski J; Hristov AC; Tsai HL; Bhojwani D; Meyer JA; Carroll WL; Belton A; Resar LM
Leuk Lymphoma; 2013 Nov; 54(11):2565-7. PubMed ID: 23472968
[No Abstract] [Full Text] [Related]
37. The High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression.
Mussnich P; D'Angelo D; Leone V; Croce CM; Fusco A
Mol Oncol; 2013 Jun; 7(3):531-42. PubMed ID: 23384558
[TBL] [Abstract][Full Text] [Related]
38. High mobility group A1 protein acts as a new target of Notch1 signaling and regulates cell proliferation in T leukemia cells.
Xi Y; Li YS; Tang HB
Mol Cell Biochem; 2013 Feb; 374(1-2):173-80. PubMed ID: 23229232
[TBL] [Abstract][Full Text] [Related]
39. HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks.
Shah SN; Kerr C; Cope L; Zambidis E; Liu C; Hillion J; Belton A; Huso DL; Resar LM
PLoS One; 2012; 7(11):e48533. PubMed ID: 23166588
[TBL] [Abstract][Full Text] [Related]
40. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
